August Bioservices, a locally based pharmaceutical manufacturing and support services company, announced Thursday it raised $65 million in Series B funding. 

In May 2021, the company closed a $23.6 million Series A extension round. The most recent funding was led by Oak HC/FT (Healthcare and FinTech) with participation from Polaris Partners, with the latter taking the lead on the Series A funding. 

Pharma manufacturing firm lands VC, new leaders

Jenn Adams